CONMED Corp — Director's Dealing 2018

Feb 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-02-01

Reporting Person: POMILIO LUKE A (Advisor to CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	Common Stock	S	18023	$63.3762	Disposed	0	Direct
2018-02-01	Common Stock	M	18400	$51.30	Acquired	18400	Direct
2018-02-01	Common Stock	F	16438	$63.35	Disposed	1962	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Sars (Stock Appreciation Rights)	$51.30	M	18400	Disposed	2025-02-27	Common Stock (18400)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.